Date palm pollen supplementation was associated with statistically significant improvements in sexual function, sexual satisfaction, and sexual quality of life among postmenopausal women, according to findings from a double-blind, randomized, placebo-controlled clinical trial published in the peer-reviewed journal BMC Complementary Medicine and Therapies. Conducted by researchers Fatemeh Aali, Zahra Lorigooini, Soleiman Kheiri, and Farangis Sharifi, the trial evaluated whether oral supplementation with date palm pollen could alleviate common postmenopausal sexual health difficulties over a two-month intervention timeframe. Across the study period, postmenopausal participants assigned to the herbal intervention demonstrated notable, measurable increases across all evaluated sexual health metrics, whereas participants assigned to the placebo control group exhibited largely unchanged or slightly reduced scores.
The investigation was specifically designed to examine sexual health challenges that frequently emerge following the menopausal transition, when hormonal, physical, and psychological changes can combine to produce female sexual dysfunction, diminished sexual satisfaction, and a broader impairment in overall sexual quality of life. In light of expanding clinical and public interest in complementary and herbal therapies for managing menopausal symptoms, the research team sought to evaluate the therapeutic potential of date palm pollen. The primary objective of the study was to determine whether structured supplementation with this traditional botanical product could provide measurable relief and quantifiable improvements in sexual function, satisfaction, and quality of life among postmenopausal women.
To evaluate the intervention under controlled conditions, the researchers organized a double-blind randomized clinical trial enrolling a total of 130 postmenopausal women. The mean age of the enrolled study participants was 52.3 years, with a standard deviation of 3.1 years. The women were randomly allocated in equal numbers into two distinct study arms, comprising 65 participants in the active intervention group receiving date palm pollen supplementation and 65 participants in the comparison group receiving an identical placebo. Before the intervention began, the study team thoroughly assessed baseline demographic and clinical characteristics for all 130 participants to record their pre-treatment clinical status and ensure proper documentation of participant backgrounds.
Throughout the trial duration, the investigators tracked participant progress at three structured timepoints: initially at baseline prior to starting supplementation, again at one month following the start of the intervention, and finally at two months post-intervention. To measure the outcomes accurately, the researchers administered validated questionnaires evaluating female sexual function, sexual satisfaction, and sexual quality of life at each scheduled assessment point. Because preliminary evaluations revealed that the resulting outcome variables were not normally distributed, the researchers avoided conventional parametric statistical tests. Instead, they conducted a rigorous nonparametric longitudinal analysis using the specialized nparLD package in the R statistical environment, allowing them to simultaneously assess overall group effects, longitudinal time effects, and group-by-time interaction effects across the study intervals.
The nonparametric longitudinal analysis revealed statistically significant group-by-time interaction effects for female sexual function, sexual satisfaction, and sexual quality of life, with all three interaction parameters reaching significance at p < 0.001. These significant interaction effects indicated distinctly different patterns of change over time between the two participant groups. In the date palm pollen supplementation group, median scores and interquartile ranges demonstrated substantial, progressive gains across all three evaluated dimensions from baseline to the two-month mark. Specifically, female sexual function scores increased from a baseline median of 18.5, with an interquartile range of 16.3 to 19.8, to a two-month median of 26.2, with an interquartile range of 25.1 to 27.9. In parallel, sexual satisfaction scores rose from a baseline median of 84, with an interquartile range of 78.5 to 90, to 106, with an interquartile range of 99 to 109, at two months.
The positive trajectory among participants receiving date palm pollen was further reflected in sexual quality of life scores, which increased from a baseline median of 71, with an interquartile range of 59 to 81, to a two-month median of 91.5, with an interquartile range of 79.7 to 99. In sharp contrast, outcome scores among participants assigned to the placebo control group remained relatively stable or showed slight decreases over the identical two-month evaluation window, indicating that the observed improvements were concentrated within the active intervention cohort. However, the study authors emphasized that these favorable results must be interpreted cautiously. They noted important methodological constraints, pointing specifically to the presence of baseline imbalances between the study groups as well as the limitations inherent in a short follow-up period of only two months.
To validate these findings and clarify the broader therapeutic profile of date palm pollen, the researchers emphasized that additional randomized clinical trials will be necessary. They recommended that future studies incorporate larger participant sample sizes, extended follow-up observation periods, standardized dosages of the pollen supplement, and comprehensive biological hormonal assessments to confirm both the long-term efficacy and safety of the intervention. The study was conducted in accordance with clinical research reporting standards and was officially registered with the Iranian Registry of Clinical Trials under the trial registration identifier IRCT20241204063940N1 on 22 June 2025.
Subject of Research: Date palm pollen supplementation and postmenopausal sexual health
Article Title: Date palm pollen supplementation and sexual health in postmenopausal women: a double-blind randomized placebo-controlled trial
Article References: Aali, F., Lorigooini, Z., Kheiri, S., & Sharifi, F. (2026). Date palm pollen supplementation and sexual health in postmenopausal women: a double-blind randomized placebo-controlled trial. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05674-y
Image Credits: AI Generated
DOI: 10.1186/s12906-026-05674-y
Keywords: date palm pollen, postmenopausal women, sexual function, sexual satisfaction, sexual quality of life, female sexual dysfunction, randomized controlled trial, placebo-controlled trial, double-blind trial, complementary medicine, herbal therapies, nparLD package, nonparametric longitudinal analysis, menopausal health, Iranian Registry of Clinical Trials, interaction effects, hormonal changes, supplementation trial
News Source: Ophelia Keating. (November 14, 2026). Date Palm Pollen Linked to Improved Sexual Function in Postmenopausal Women. Scienmag.



